Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Redox Dextran-Based Self-Adapting Adhesive Hydrogels for Subconjunctival Injury to Alleviate Inflammation and Accelerate Healing.

Created on 15 Oct 2025

Authors

Boyuan An, Yuting Deng, Haohao Cui, Mengke Wang, Jiake Li, Qin Zeng, Zhanrong Li, Jingguo Li

Published in

Biomacromolecules. Oct 14, 2025. Epub Oct 14, 2025.

Abstract

Traumatic or chemical injuries to the conjunctival and subconjunctival tissue can lead to defects and associated inflammatory responses, significantly impairing the tissue repair process. Current repair methods lack effective integration of anti-inflammatory action with wound sealing. We combined redox dextran (POD) with poly(vinyl alcohol) (PVA) through physical hydrogen bonds and boronic ester bonds and achieved structural reinforcement through freeze-thawing cycles, developing a novel, self-adapting, anti-inflammatory, dual-network hydrogel adhesive (POAD). The POD surface combines both high degree of freedom primary hydroxyl groups and reactive aldehyde groups, which significantly improves the cohesive and interfacial interactions. In addition, the hydrogel adapts to complex wound shapes and degrades slowly in the presence of reactive oxygen species (ROS), relieving inflammation while making room for tissue regeneration and accelerating the tissue repair process. These properties suggest that POAD hydrogels will be an alternative strategy for future functional ocular surface reconstruction.

PMID:
41086364
Bibliographic data and abstract were imported from PubMed on 15 Oct 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 51
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement